Molecular infectious disease polymerase chain reaction (PCR) testing

Active Purchase Order Awarded Last action

Contract number
W81K0025PA095
Awardee
Awarding agency
Obligated
$1,266,089

Award facts

Opportunity
  • W81K0025QA019 Solicitation number
Contract value 20% obligated
  • $2,546,167.35 Current, with exercised options
  • $6,330,442.65 Potential, with all options
Completion date 21% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
JBSA FT SAM HOUSTON, TX 78234, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00008 $0
Exercise an Option P00007 · Pursuant to federal acquisition regulation (far) 52.217-9, option to extend the term of the contract, W81K00-25-p-A095 with biofire defense LLC. Is hereby… $0
Supplemental Agreement for work within scope P00006 $181,255
Supplemental Agreement for work within scope P00005 · The purpose of this modification is to incorporate the revised statement of objectives dated 20 march 2026 to biofire defense pathogen panel requirement on… $0
Funding Only Action P00003 · In accordance with federal acquisition regulation (far) 52.218, availability of funds, FY26 funds are available and hereby obligated for purchase order… $1,084,834
Other Administrative Action P00002 · The purpose of this modification is to remove the payment office on this purchase order. $0
Supplemental Agreement for work within scope P00004 · In accordance with federal acquisition regulation far 52.212-4(c) changes, decrease quantity, realign funds and add new reagents. -$0
Original award $0

About this award

Written by GovTribe AI ·

The Defense Health Agency issued a purchase order to Biofire Defense LLC on October 1, 2025, extending option year 1 of contract W81K00-25-P-A095 for molecular infectious disease polymerase chain reaction (PCR) testing services through September 30, 2027, with a ceiling value of $6.33 million. No set-aside applies. Work is performed at JBSA Fort Sam Houston, Texas. The contract operates under firm fixed price pricing and extends through ultimate completion on September 30, 2030, pursuant to FAR 52.217-9.

Quick answers

Who was awarded contract W81K0025PA095?

W81K0025PA095 was awarded to Biofire Defense LLC by Medical Command (Department of the Army) on October 1, 2025.

How much is contract W81K0025PA095 worth?

The government has obligated $1,266,089 on W81K0025PA095. Its current value, with exercised options, is $2,546,167. Its potential value, with all options, is $6,330,443.

Which agency awarded contract W81K0025PA095?

Medical Command (Department of the Army) awarded W81K0025PA095, with funding from Defense Health Agency (Department of Defense).

Was contract W81K0025PA095 competed?

The extent of competition for W81K0025PA095 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login